Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1026 | 1042 | 1045 | 1131 | 1298 | 1861 |
Fund Return | 2.59% | 4.16% | 4.54% | 4.2% | 5.36% | 6.41% |
Place in category | 219 | 484 | 223 | 181 | 324 | 53 |
% in Category | 31 | 73 | 39 | 35 | 72 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.13B | 18.17 | 9.14 | 13.09 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.18B | 16.91 | 7.54 | 10.23 | ||
UBS CH Vitainvest 50 World U | 4.36B | 2.45 | -0.62 | 2.66 | ||
UBS CH Institutional Fund 2 EquUSAA | 2.2B | 18.12 | 8.92 | 12.85 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.2B | 11.77 | 0.06 | 7.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.37B | 6.76 | 5.03 | 6.69 | ||
Raiffeisen Futura Swiss Stock A | 2.1B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHF | 2.05B | 2.43 | 3.56 | 5.81 | ||
UBAM Swiss Equity AD CHF Inc | 1.74B | 7.99 | -0.55 | 5.90 | ||
UBAM Swiss Equity A CHF Acc | 1.74B | 3.61 | -0.24 | 5.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.77 | 221.30 | +1.28% | |
Nestle | CH0038863350 | 9.34 | 92.16 | +0.88% | |
Novartis | CH0012005267 | 9.33 | 89.78 | +1.91% | |
UBS Group | CH0244767585 | 9.03 | 26.79 | +7.59% | |
Zurich Insurance Group | CH0011075394 | 7.67 | 451.60 | +1.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Neutral |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review